Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026)

Caris Life Sciences has reported Other Non Operating Income for 3 years, with the latest figure at -$25.1 million in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 37.02% year-over-year to -$25.1 million in Q2 2026; TTM through Jun 2026 was -$27.3 million, a 48.71% decrease from a year earlier, with the FY2025 full-year figure at -$20.6 million, down 5791.12% from the prior year.
• Other Non Operating Income was -$25.1 million for Q2 2026 at Caris Life Sciences, down from $49000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $49000.0 in Q1 2026, with the low at -$25.1 million in Q2 2026.
• Average Other Non Operating Income over 3 years is -$5.1 million, with a median of -$89000.0 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income slumped 12907.8% in 2025, then soared 388.24% in 2026.
• Over 3 years, Other Non Operating Income stood at -$26000.0 in 2024, then sank by 8026.92% to -$2.1 million in 2025, then tumbled by 1089.35% to -$25.1 million in 2026.
• The last three Other Non Operating Income figures came in at -$25.1 million (Q2 2026), $49000.0 (Q1 2026), and -$2.1 million (Q4 2025), per Business Quant data.